FR2391733A1 - Antigene contre les tumeurs et son procede de preparation - Google Patents

Antigene contre les tumeurs et son procede de preparation

Info

Publication number
FR2391733A1
FR2391733A1 FR7713521A FR7713521A FR2391733A1 FR 2391733 A1 FR2391733 A1 FR 2391733A1 FR 7713521 A FR7713521 A FR 7713521A FR 7713521 A FR7713521 A FR 7713521A FR 2391733 A1 FR2391733 A1 FR 2391733A1
Authority
FR
France
Prior art keywords
preparation
against tumors
antigen against
tumors
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7713521A
Other languages
English (en)
Other versions
FR2391733B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Original Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften eV filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Publication of FR2391733A1 publication Critical patent/FR2391733A1/fr
Application granted granted Critical
Publication of FR2391733B1 publication Critical patent/FR2391733B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Le procédé de préparation d'antigènes contre les tumeurs est caractérisé en ce qu'on traite des cellules tumorales préparables en suspension de manière connue avec un composé de formule générale 1:
FR7713521A 1976-05-04 1977-05-04 Antigene contre les tumeurs et son procede de preparation Granted FR2391733A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762619715 DE2619715A1 (de) 1976-05-04 1976-05-04 Tumor-antigen und verfahren zu dessen herstellung

Publications (2)

Publication Number Publication Date
FR2391733A1 true FR2391733A1 (fr) 1978-12-22
FR2391733B1 FR2391733B1 (fr) 1980-03-07

Family

ID=5977057

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7713521A Granted FR2391733A1 (fr) 1976-05-04 1977-05-04 Antigene contre les tumeurs et son procede de preparation

Country Status (17)

Country Link
JP (1) JPS52134011A (fr)
AT (1) AT362497B (fr)
AU (1) AU517395B2 (fr)
BE (1) BE854269A (fr)
CA (1) CA1077840A (fr)
DE (1) DE2619715A1 (fr)
DK (1) DK194477A (fr)
FR (1) FR2391733A1 (fr)
GB (1) GB1575545A (fr)
IE (1) IE44943B1 (fr)
IL (1) IL51989A (fr)
IT (1) IT1074325B (fr)
LU (1) LU77245A1 (fr)
NL (1) NL7704724A (fr)
NZ (1) NZ183980A (fr)
SE (1) SE7705070L (fr)
ZA (1) ZA772648B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0087087A2 (fr) * 1982-02-13 1983-08-31 Nippon Shinyaku Company, Limited Méthode de fabrication de substance biologiquement active

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4551532A (en) * 1980-05-08 1985-11-05 Takeda Chemical Industries, Ltd. Ethylene glycol derivatives having anti-protozoan, anti-fungal and anti-tumor activity
US4444766A (en) * 1980-10-21 1984-04-24 Boehringer Mannheim Gmbh Sulfur-containing phospholipid compounds and therapeutic compositions
JPS5772914A (en) 1980-10-22 1982-05-07 Takeda Chem Ind Ltd Antitumor agent
US4562179A (en) * 1982-04-19 1985-12-31 Fujisawa Pharmaceutical Co., Ltd. Phospholipid derivatives, and pharmaceutical composition of the same
JPS5933223A (ja) * 1982-08-20 1984-02-23 Koken Kk 人の悪性腫瘍細胞増殖抑制剤
JPS6081194A (ja) * 1983-10-11 1985-05-09 Takeda Chem Ind Ltd ケトアルキルリン脂質
JP2561478B2 (ja) * 1986-07-22 1996-12-11 武田薬品工業株式会社 グリセリン誘導体
US5030733A (en) * 1987-07-23 1991-07-09 Hoechst-Roussel Pharmaceticals Incorporated Hydroxy-, alkoxy- and benzyloxy-substituted phospholipids
US5145844A (en) * 1987-07-23 1992-09-08 Hoechst-Roussel Pharmaceuticals Incorporated Methods of using hydroxy-, alkoxy- and benzyloxy-substituted phospholipids to treat phospholipase A2 -mediated conditions and to alleviate pain
US5036152A (en) * 1988-03-10 1991-07-30 Hoechst-Roussel Pharmaceuticals Incorporated Alkoxycarbonylalkylphospholipids and alkylaminocarbonylalkylphospholipids
US4888328A (en) * 1988-03-10 1989-12-19 Hoeschst-Roussel Incorporated Alkoxycarbonylalkylphospholipids and alkylaminocarbonylalkylphospholipids
DE3906952A1 (de) * 1989-03-04 1990-09-06 Boehringer Mannheim Gmbh (3-(c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)6(pfeil abwaerts)-c(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)8(pfeil abwaerts))alkansulfinyl- und sulfonyl-2-methoxymethyl-propyl)-(2-trimethylammonio-ethyl) phosphate, verfahren zu deren herstellung diese verbindungen enthaltende arzneimittel

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0087087A2 (fr) * 1982-02-13 1983-08-31 Nippon Shinyaku Company, Limited Méthode de fabrication de substance biologiquement active
EP0087087A3 (fr) * 1982-02-13 1983-10-19 Nippon Shinyaku Company, Limited Méthode de fabrication de substance biologiquement active

Also Published As

Publication number Publication date
NL7704724A (nl) 1977-11-08
IT1074325B (it) 1985-04-20
DE2619715A1 (de) 1977-11-24
IL51989A0 (en) 1977-07-31
BE854269A (fr) 1977-11-04
JPS52134011A (en) 1977-11-09
AT362497B (de) 1981-05-25
IE44943L (en) 1977-11-04
CA1077840A (fr) 1980-05-20
SE7705070L (sv) 1977-11-05
DK194477A (da) 1977-11-05
ZA772648B (en) 1978-04-26
IL51989A (en) 1980-01-31
FR2391733B1 (fr) 1980-03-07
IE44943B1 (en) 1982-05-19
NZ183980A (en) 1980-04-28
LU77245A1 (fr) 1977-12-13
AU2481877A (en) 1978-11-09
ATA313277A (de) 1980-10-15
GB1575545A (en) 1980-09-24
AU517395B2 (en) 1981-07-30

Similar Documents

Publication Publication Date Title
FR2391733A1 (fr) Antigene contre les tumeurs et son procede de preparation
ES477060A1 (es) Un metodo para la preparacion de interferon.
PT87086A (pt) Active specific immune suppression
HUT52153A (en) Process for producing chimeric antibody specific to human tumour antigene
ATE41924T1 (de) Vitamin d3-derivate mit einem substituierten in position 2.
EP0547165A4 (fr)
PT72301A (en) Process for the detection of human cancer cells with antibodies to human cancer nucleolar antigens
GB2086376B (en) Process for the production of acrylamide using immobilised cells
FR2427339A1 (fr) Nouveaux derives optiquement actifs d'oxazaphosphorine et leur procede de preparation
GB1359260A (en) Tation yohimbine derivatives process for their preparation and their applications
HUT47033A (en) Process for production of medical compositions against tumor
JPS51148085A (en) Fermentated medium and production of yeast for feeding animal by same
PL214277A1 (pl) Sposob wytwarzania agregatow bakteryjnych komorek o zwiekszonej twardosci czastek
IL62988A0 (en) Germanium compounds,a process for the preparation thereof,a process for the preparation of a medicine using such a germanium compound for the treatment of cancer,as well as the shaped medicine thus formed and obtained
FR2370736A1 (fr) Nouvelles 1-acyl 2-imidazolines et procede pour leur preparation
FR2427099B1 (fr)
ES8306161A1 (es) Un procedimiento para la preparacion de nuevos derivados de nitrosourea.
CA1273347C (fr)
SU890688A1 (ru) Способ получения дитрет.-бутоксиметана
FR2414919A1 (fr) Procede de preparation d'un complexe de substance active immunologique dirige contre la croissance maligne a partir de cellules
FR2396000A1 (fr) Nouveaux derives a-acetyleniques d'histamine utiles notamment comme antihistaminiques et leur procede de preparation
PT74944A (en) Process of inoculation for producing xanthan gum
FR2552429B1 (fr) Procede de preparation de quinolinones-4
JPS51124512A (en) Producing method of assembled frame body for nursery plant growing
OA06266A (fr) Procédé de préparation d'un extrait de globularia utile notamment en thérapeutiques.

Legal Events

Date Code Title Description
ST Notification of lapse